This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 2 EPO patents. Top assignee: Innovation Ulster Limited. Active years: 2015.
Company Filing History:
Years Active: 2015
Title: Christian Holscher: Pioneering Innovations in Cognitive Function Treatment
Introduction
Christian Holscher is an accomplished inventor based in Coleraine, GB, recognized for his significant contributions to the field of cognitive health. With a total of two patents to his name, Holscher is focused on developing innovative therapies aimed at addressing disorders associated with dysfunctional synaptic transmission. His groundbreaking work holds promise for improving cognitive function in various populations.
Latest Patents
Holscher's latest patents include:
1. **Use of GLP-1 Analogues for the Treatment of Disorders Associated with Dysfunctional Synaptic Transmission**: This invention relates to a peptide analogue of glucagon-like peptide-1 (7-36). It is designed to prophylactically prevent, improve, or reverse diminished cognitive function by enhancing synaptic transmission through sustained long-term potentiation (LTP). The approach seeks to delay the onset of impaired cognitive processes and offers potential treatment avenues for neurodegeneration, trauma, and age-related cognitive decline.
2. **Use of GIP for the Treatment of Disorders Associated with Dysfunctional Synaptic Transmission**: This patent focuses on a peptide comprising at least 12 amino acid residues from the N-terminal end of gastric inhibitory polypeptide or its analogs. Similar to his GLP-1 analogue, this invention aims to improve, reverse, or prevent cognitive decline by modulating synaptic transmission. It also addresses hyperexcitability-type disorders, offering a dual-directional approach to cognitive health enhancement.
Career Highlights
Christian Holscher has made significant strides in the field of cognitive health through his ongoing research and innovations. His work primarily carried out with Innovation Ulster Limited, positions him at the forefront of scientific advancement in neurology and cognitive function treatment. He has dedicated his career to exploring the complexities of synaptic transmission and its impact on cognitive abilities.
Collaborations
Throughout his career, Holscher has collaborated with notable colleagues, including Peter Raymond Flatt and Victor Alan Gault. These partnerships have enriched his research endeavors and contributed to the development of pioneering therapies aimed at improving cognitive function.
Conclusion
Christian Holscher's work exemplifies the innovative spirit in addressing challenges related to cognitive health. Through his patents and research at Innovation Ulster Limited, he continues to push the boundaries of science and offers hope for effective treatments for cognitive dysfunction. His contributions not only enhance our understanding of brain function but also pave the way for future advancements in neurological health.